EQUILLIUM, INC. Financing Cash Flow
EQUILLIUM, INC. (EQ) reported Financing Cash Flow of $35.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- EQUILLIUM, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $42.00K.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $35.35M, a 38741.76% increase year-over-year.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $283.00K, a 287.67% increase year-over-year.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $30.07M.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for fiscal 2025 was $30.43M, a 18453.05% increase from fiscal 2024.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for fiscal 2024 was $164.00K.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$9.23M.
- EQUILLIUM, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$1.22M, a 103.91% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 7 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 10 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $35.39M 10-Q · filed 2026-08-13 | $35.67M derived: sum of 3 quarters · filed 2026-08-13 | $65.74M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $35.35M 10-Q · filed 2026-05-13 | $35.63M derived: sum of 2 quarters · filed 2026-05-13 | $65.70M derived: sum of 3 quarters · filed 2026-05-13 | $65.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $30.35M derived: sum of 2 quarters · filed 2026-03-25 | $30.34M derived: sum of 3 quarters · filed 2026-08-13 | $30.43M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $30.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $30.05M derived: sum of 2 quarters · filed 2026-08-13 | $30.14M 10-Q · filed 2025-11-13 | $30.22M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $75.00K 10-Q · filed 2026-08-13 | $148.00K derived: sum of 3 quarters · filed 2026-08-13 | $148.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $91.00K 10-Q · filed 2026-05-13 | $164.00K derived: sum of 2 quarters · filed 2026-05-13 | $164.00K derived: sum of 3 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $73.00K derived: sum of 2 quarters · filed 2026-03-25 | $164.00K 10-K · filed 2026-03-25 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $91.00K 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | $91.00K 10-Q · filed 2025-08-14 | |||||||
| 2023-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$181.00K derived: sum of 2 quarters · filed 2025-03-27 | -$7.80M derived: sum of 3 quarters · filed 2025-03-27 | -$9.23M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$7.88M derived: sum of 2 quarters · filed 2024-11-13 | -$9.31M 10-Q · filed 2024-11-13 | -$10.66M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$7.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$9.05M 10-Q · filed 2024-08-08 | -$10.40M derived: sum of 3 quarters · filed 2024-08-08 | -$10.40M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$1.43M 10-Q · filed 2024-05-09 | -$2.79M derived: sum of 2 quarters · filed 2024-05-09 | -$2.79M derived: sum of 3 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$1.36M derived: sum of 2 quarters · filed 2024-03-25 | -$1.22M 10-K · filed 2024-03-25 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $141.00K 10-Q · filed 2023-11-08 | ||||||
| 2022-06-30 | $141.00K 10-Q · filed 2023-08-09 | |||||||
| 2021-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $399.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.10M derived: sum of 3 quarters · filed 2023-03-23 | $31.06M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $174.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $872.00K derived: sum of 2 quarters · filed 2022-11-14 | $30.84M 10-Q · filed 2022-11-14 | $30.85M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $698.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $30.66M 10-Q · filed 2022-08-15 | $30.67M derived: sum of 3 quarters · filed 2022-08-15 | $83.74M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $29.96M 10-Q · filed 2022-05-12 | $29.98M derived: sum of 2 quarters · filed 2022-05-12 | $83.04M derived: sum of 3 quarters · filed 2022-05-12 | $83.13M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $53.07M derived: sum of 2 quarters · filed 2022-03-23 | $53.17M derived: sum of 3 quarters · filed 2022-03-23 | $53.95M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $53.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $53.16M derived: sum of 2 quarters · filed 2021-11-10 | $53.93M 10-Q · filed 2021-11-10 | $53.83M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $871.00K 10-Q · filed 2021-08-10 | $766.00K derived: sum of 3 quarters · filed 2021-08-10 | |||||
| 2020-03-31 | $775.00K 10-Q · filed 2021-05-13 | $670.00K derived: sum of 2 quarters · filed 2021-05-13 | ||||||
| 2019-12-31 | -$105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $9.84M 10-K · filed 2021-03-24 | ||||||
| 2019-09-30 | $9.94M 10-Q · filed 2020-11-10 | |||||||
| 2018-12-31 | $64.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $64.76M derived: sum of 2 quarters · filed 2020-03-26 | $66.36M 10-K · filed 2020-03-26 | $66.37M 10-K · filed 2019-03-27 | ||||
| 2018-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.60M 10-Q · filed 2019-11-12 | $1.60M 10-Q · filed 2018-11-15 | |||||
| 2018-06-30 | $1.60M 10-Q · filed 2019-08-12 | |||||||
| 2017-12-31 | $7.77M 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | $1.00M 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |